NXLIW Form 25 Filed — Nasdaq to Remove Listing/Registration

Rhea-AI Filing Summary

Nexalin Technology, Inc. (symbol NXLIW) is the subject of a Form 25 notification filed under the Securities Exchange Act to remove a class of its securities from listing and/or registration on the Nasdaq Stock Market LLC. The filing names the issuer and provides its principal office at 1776 Yorktown, Suite 550, Houston, Texas 77056 and a contact telephone number as listed in the form.

The document duplicates the regulatory checkboxes for rule provisions governing removal and states that Nasdaq certifies it has complied with the applicable procedures to strike or withdraw the class of securities. The form includes the standard OMB approval legend and a note that the Form 25 and attached notice comply with the applicable rules.

Positive

• Nasdaq certified compliance with the procedural rules required to file Form 25
• Issuer identity and contact (address and telephone) are clearly provided in the filing

Negative

• Form 25 notifies removal of a class of Nexalin Technology securities from Nasdaq listing/registration
• Filing lacks key timing details such as the effective delisting date or whether withdrawal was voluntary

Insights

Exchange Compliance Analyst

Form 25 indicates Nasdaq moved to remove NXLIW from listing/registration.

The filing shows Nasdaq initiated or processed a notice under the Exchange Act to strike the class of securities for Nexalin Technology, Inc. from the Nasdaq market and affirms procedural compliance with the specified SEC rules governing delisting/withdrawal.

This action is procedural and triggers standard administrative follow‑ups such as public notice and final removal processing; monitor subsequent filings for the effective removal date or any issuer responses.

Equity Listing Specialist

The document records listing-removal mechanics but contains no financial detail or effective dates.

The form identifies the issuer, exchange, and cites rule provisions but does not state whether the removal was voluntary or due to noncompliance, nor does it provide an effective delisting date or impact on outstanding shares.

Investors and holders should look for follow-on notices or filings that specify the effective date and any transfer of trading to OTC markets; this filing alone does not quantify shareholder effects.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

333-261989

Issuer:	Nexalin Technology, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1776 Yorktown, Suite 550
	Houston	TEXAS	77056
Telephone number:					2,818,308,900

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Warrant expiring 09/22/2025

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-09-19	By	Jennifer Fainer		CDO Analyst
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 25 filed for Nexalin Technology, Inc. (NXLIW) state?

The Form 25 notifies the removal or withdrawal of a class of Nexalin Technology, Inc. securities from Nasdaq and certifies Nasdaq's procedural compliance.

Does the Form 25 for NXLIW say why the securities are being removed?

No. The filing cites applicable Nasdaq/SEC rule provisions but does not state the reason (voluntary withdrawal versus exchange-initiated delisting).

Does the filing include an effective date for the Nasdaq removal of NXLIW?

No. The document does not provide an effective delisting date or timeline.

Where is Nexalin Technology, Inc. headquartered according to the filing?

The filing lists the principal executive office at 1776 Yorktown, Suite 550, Houston, Texas 77056.

Will NXLIW continue to trade after the Form 25 filing?

The Form 25 itself does not state subsequent trading arrangements; follow-up notices or exchange records are needed to confirm whether trading moves to another venue or ceases.